User profiles for Jeffrey B. Bonanno
Jeffrey B. BonannoDepartment of Biochemistry, Albert Einstein College of Medicine Verified email at einsteinmed.edu Cited by 8022 |
Type VI secretion apparatus and phage tail-associated protein complexes share a common evolutionary origin
…, UA Ramagopal, JB Bonanno… - Proceedings of the …, 2009 - National Acad Sciences
Protein secretion is a common property of pathogenic microbes. Gram-negative bacterial
pathogens use at least 6 distinct extracellular protein secretion systems to export proteins …
pathogens use at least 6 distinct extracellular protein secretion systems to export proteins …
[HTML][HTML] Recognition of polyadenylate RNA by the poly (A)-binding protein
The cocrystal structure of human poly(A)-binding protein (PABP) has been determined at
2.6 Å resolution. PABP recognizes the 3′ mRNA poly(A) tail and plays critical roles in …
2.6 Å resolution. PABP recognizes the 3′ mRNA poly(A) tail and plays critical roles in …
Structural genomics: beyond the human genome project
SK Burley, SC Almo, JB Bonanno, M Capel… - Nature …, 1999 - nature.com
With access to whole genome sequences for various organisms and imminent completion
of the Human Genome Project, the entire process of discovery in molecular and cellular …
of the Human Genome Project, the entire process of discovery in molecular and cellular …
Mechanism of action of a flavin-containing monooxygenase
S Eswaramoorthy, JB Bonanno… - Proceedings of the …, 2006 - National Acad Sciences
Elimination of nonnutritional and insoluble compounds is a critical task for any living
organism. Flavin-containing monooxygenases (FMOs) attach an oxygen atom to the insoluble …
organism. Flavin-containing monooxygenases (FMOs) attach an oxygen atom to the insoluble …
Structural genomics of protein phosphatases
SC Almo, JB Bonanno, JM Sauder, S Emtage… - Journal of structural and …, 2007 - Springer
The New York SGX Research Center for Structural Genomics (NYSGXRC) of the NIGMS
Protein Structure Initiative (PSI) has applied its high-throughput X-ray crystallographic structure …
Protein Structure Initiative (PSI) has applied its high-throughput X-ray crystallographic structure …
[HTML][HTML] Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity
MC Ho, C Wilczek, JB Bonanno, L Xing, J Seznec… - PloS one, 2013 - journals.plos.org
The arginine methyltransferase PRMT5-MEP50 is required for embryogenesis and is
misregulated in many cancers. PRMT5 targets a wide variety of substrates, including histone …
misregulated in many cancers. PRMT5 targets a wide variety of substrates, including histone …
Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab
…, SC Garrett-Thomson, JB Bonanno… - Proceedings of the …, 2017 - National Acad Sciences
Rational modulation of the immune response with biologics represents one of the most
promising and active areas for the realization of new therapeutic strategies. In particular, the use …
promising and active areas for the realization of new therapeutic strategies. In particular, the use …
Structural insights into thioether bond formation in the biosynthesis of sactipeptides
Sactipeptides are ribosomally synthesized peptides that contain a characteristic thioether
bridge (sactionine bond) that is installed posttranslationally and is absolutely required for their …
bridge (sactionine bond) that is installed posttranslationally and is absolutely required for their …
Anti–CTLA-4 therapy requires an Fc domain for efficacy
…, E Fedorov, AA Fedorov, JB Bonanno… - Proceedings of the …, 2018 - National Acad Sciences
Ipilimumab, a monoclonal antibody that recognizes cytotoxic T lymphocyte antigen (CTLA)-4,
was the first approved “checkpoint”-blocking anticancer therapy. In mouse tumor models, …
was the first approved “checkpoint”-blocking anticancer therapy. In mouse tumor models, …
[HTML][HTML] Structural insights into substrate and inhibitor binding sites in human indoleamine 2, 3-dioxygenase 1
…, D Batabyal, S Karkashon, JB Bonanno… - Nature …, 2017 - nature.com
Human indoleamine 2,3-dioxygenase 1 (hIDO1) is an attractive cancer immunotherapeutic
target owing to its role in promoting tumoral immune escape. However, drug development …
target owing to its role in promoting tumoral immune escape. However, drug development …